These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
393 related articles for article (PubMed ID: 37955686)
21. Aspartate beta-hydroxylase domain containing 1 as a prognostic marker associated with immune infiltration in skin cutaneous melanoma. Sun S; Deng M; Wen J; Chen X; Xu J; Liu Y; Wan H; Wang J; Yan L; He Y; Xu Y BMC Cancer; 2023 Mar; 23(1):292. PubMed ID: 37004045 [TBL] [Abstract][Full Text] [Related]
22. Melanoma Molecular Subtypes and Development of Prognostic and Immunotherapy-Related Genetic Characteristics by Ferroptosis Gene Analysis. Xu L; Zhang Y; Liu T; Wang L; Zhao Z; Zhang X; Li X; Wu W; Yu S Comput Math Methods Med; 2022; 2022():2992939. PubMed ID: 35516454 [TBL] [Abstract][Full Text] [Related]
24. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Liu X; Wang J Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111 [TBL] [Abstract][Full Text] [Related]
25. Prediction of survival and immunotherapy response by the combined classifier of G protein-coupled receptors and tumor microenvironment in melanoma. Shen K; Wang Q; Wang L; Yang Y; Ren M; Li Y; Gao Z; Zheng S; Ding Y; Ji J; Wei C; Zhang T; Zhu Y; Feng J; Qin F; Yang Y; Wei C; Gu J Eur J Med Res; 2023 Sep; 28(1):352. PubMed ID: 37716991 [TBL] [Abstract][Full Text] [Related]
26. Role of single-cell ferroptosis regulation in intercellular communication and skin cutaneous melanoma progression and immunotherapy. Song B; Peng Y; Zheng Y; Zhu Y; Liu W; Wang K; Cui Z; Song B Cancer Immunol Immunother; 2023 Nov; 72(11):3523-3541. PubMed ID: 37638981 [TBL] [Abstract][Full Text] [Related]
27. Novel lactylation-related signature to predict prognosis for pancreatic adenocarcinoma. Peng T; Sun F; Yang JC; Cai MH; Huai MX; Pan JX; Zhang FY; Xu LM World J Gastroenterol; 2024 May; 30(19):2575-2602. PubMed ID: 38817665 [TBL] [Abstract][Full Text] [Related]
28. Multi-omics analysis of tumor mutation burden combined with immune infiltrates in melanoma. Jiang F; Wu C; Wang M; Wei K; Zhou G; Wang J Clin Chim Acta; 2020 Dec; 511():306-318. PubMed ID: 33164879 [TBL] [Abstract][Full Text] [Related]
29. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma. Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266 [TBL] [Abstract][Full Text] [Related]
30. KIF4A functions as a diagnostic and prognostic biomarker and regulates tumor immune microenvironment in skin cutaneous melanoma. Zeng S; Wang Q; Zhou R; Wang D Pathol Res Pract; 2024 Feb; 254():155166. PubMed ID: 38286055 [TBL] [Abstract][Full Text] [Related]
31. Prognostic and immune infiltration implications of SIGLEC9 in SKCM. Yang P; Jiang Y; Chen R; Yang J; Liu M; Huang X; Xu G; Hao R Diagn Pathol; 2024 Aug; 19(1):112. PubMed ID: 39153970 [TBL] [Abstract][Full Text] [Related]
32. Identification of m6A-related lncRNAs-based signature for predicting the prognosis of patients with skin cutaneous melanoma. Lin W; Tan ZY; Fang XC SLAS Technol; 2024 Feb; 29(1):100101. PubMed ID: 37541541 [TBL] [Abstract][Full Text] [Related]
33. Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma. Chen J; Yu N; Ou S; Wang X; Li H; Zhu H J Cancer Res Clin Oncol; 2023 Oct; 149(13):11619-11634. PubMed ID: 37401939 [TBL] [Abstract][Full Text] [Related]
34. Machine learning-based identification of an immunotherapy-related signature to enhance outcomes and immunotherapy responses in melanoma. Deng Z; Liu J; Yu YV; Jin YN Front Immunol; 2024; 15():1451103. PubMed ID: 39355255 [TBL] [Abstract][Full Text] [Related]
35. Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma. Ding Y; Zhao Z; Cai H; Zhou Y; Chen H; Bai Y; Liu Z; Liu S; Zhou W Front Immunol; 2023; 14():1304466. PubMed ID: 38077400 [TBL] [Abstract][Full Text] [Related]
36. Gene expression and immune infiltration in melanoma patients with different mutation burden. Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680 [TBL] [Abstract][Full Text] [Related]
37. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM. Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y Front Immunol; 2024; 15():1387316. PubMed ID: 38660305 [TBL] [Abstract][Full Text] [Related]
38. A novel pyroptosis-related LncRNA signature predicts prognosis and indicates tumor immune microenvironment in skin cutaneous melanoma. Zhong J; Wang Z; Houssou Hounye A; Liu J; Zhang J; Qi M Life Sci; 2022 Oct; 307():120832. PubMed ID: 35940218 [TBL] [Abstract][Full Text] [Related]
39. Low expression of endoplasmic reticulum stress-related gene SERP1 is associated with poor prognosis and immune infiltration in skin cutaneous melanoma. Fan Y; Liang X; Yu D Aging (Albany NY); 2021 Oct; 13(19):23036-23071. PubMed ID: 34613934 [TBL] [Abstract][Full Text] [Related]
40. A promising anoikis-related prognostic signature predicts prognosis of skin cutaneous melanoma. Yue Z; Wang D; Li X J Cancer Res Clin Oncol; 2023 Dec; 149(20):17757-17770. PubMed ID: 37930439 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]